Revenue

EBITDA

Earnings

Price per share at the end of the period divided by the last reported earnings

Free Cash Flow

Cohen & Steers, Inc. is a publicly owned asset management holding company. Through its subsidiaries, the firm provides its services to institutional investors, including pension funds, endowments, and foundations. It manages separate client-focused equity, fixed income, multi-asset, and commodity portfolios through its subsidiaries. The firm launches and manages equity, fixed income, balanced, and multi-asset mutual funds through its subsidiaries. Through its subsidiaries, it also launches and manages hedge funds. The firm invests in public equity, fixed income, and commodity markets across the globe through its subsidiaries. Through its subsidiaries, it invests in companies operating in the real estate sector, including real estate investment trusts, infrastructure sector, and natural energy resources sector for its equity and fixed income investments. The firm also invests in preferred securities for its fixed income investments through its subsidiaries. Cohen & Steers, Inc. was founded in 1986 and is based in New York, with additional offices in London, United Kingdom; Central, Hong Kong; Tokyo, Japan; and Seattle, Washington.

Cohen & Steers, Inc.

The significance of a company's longevity in the market

Years since IPO

Evaluation of recent trends and improvements in the company's revenue

Revenue Growth

Assessment of recent increases in earnings per share, indicating profitability

EPS Growth

Review of the company's ability to generate free cash flow over recent periods

FCF Growth

Analysis of Return on Equity, showing how effectively the company uses equity to generate profits

Examination of debt levels using Debt/Assets and Debt/EBITDA to ensure manageable leverage

Debt

NEW YORK , DEC. 10, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) IS ADDING TO ITS SUITE OF ACTIVELY MANAGED EXCHANGE-TRADED FUNDS (ETFS) WITH THE LAUNCH OF TWO NEW STRATEGIES: THE COHEN & STEERS INFRASTRUCTURE OPPORTUNITIES ACTIVE ETF (NYSE ARCA: CSIO) AND THE COHEN & STEERS SHORT DURATION PREFERRED AND INCOME ACTIVE ETF (NYSE ARCA: CSSD). CSIO AND CSSD BEGAN TRADING ON THE NYSE ARCA TODAY.

COHEN & STEERS LAUNCHES INFRASTRUCTURE OPPORTUNITIES AND SHORT DURATION PREFERRED SECURITIES ACTIVE ETFS

FROM HANDSHAKE TO BREAKTHROUGH: HOW RAKOVINA & VARIATIONAL AI ARE CRACKING THE CODE ON CNS-PENETRANT CANCER THERAPIES FROM HANDSHAKE TO BREAKTHROUGH: HOW RAKOVINA & VARIATIONAL AI ARE CRACKING THE CODE ON CNS-PENETRANT CANCER THERAPIES

RAKOVINA THERAPEUTICS ANNOUNCES UPCOMING WEBINAR WITH VARIATIONAL AI

NEW YORK , DEC. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) TODAY REPORTED PRELIMINARY ASSETS UNDER MANAGEMENT OF $91.9 BILLION AS OF NOVEMBER 30, 2025, AN INCREASE OF $1.3 BILLION FROM ASSETS UNDER MANAGEMENT OF $90.6 BILLION AT OCTOBER 31, 2025. THE INCREASE WAS DUE TO MARKET APPRECIATION OF $2.0 BILLION, PARTIALLY OFFSET BY NET OUTFLOWS OF $502 MILLION AND DISTRIBUTIONS OF $151 MILLION.

COHEN & STEERS ANNOUNCES PRELIMINARY ASSETS UNDER MANAGEMENT AND NET FLOWS FOR NOVEMBER 2025

NEW YORK , DEC. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS INCOME OPPORTUNITIESREIT, INC. ("CNSREIT") ANNOUNCED TODAY ITS ACQUISITION OF SPRINGS PLAZA, A GROCERY-ANCHORED OPEN-AIR SHOPPING CENTER IN BONITA SPRINGS, FLA. THE ACQUISITION WAS MADE THROUGH A PROGRAMMATIC JOINT VENTURE WITH PHILLIPS EDISON & COMPANY (NASDAQ: PECO  "PECO"), A PUBLICLY-TRADED OWNER AND OPERATOR OF GROCERY-ANCHORED U.S. NEIGHBORHOOD SHOPPING CENTERS.

COHEN & STEERS INCOME OPPORTUNITIES REIT, INC. ACQUIRES ALDI-ANCHORED SHOPPING CENTER IN BONITA SPRINGS, FLORIDA

NEW YORK , DEC. 8, 2025 /PRNEWSWIRE/ --COHEN & STEERS, INC. (NYSE: CNS) ANNOUNCED TODAY THAT IT HAS BEEN NAMED AS ONE OF THE "BEST PLACES TO WORK IN MONEY MANAGEMENT" FOR THE SIXTH CONSECUTIVE YEAR BY PENSIONS & INVESTMENTS, A GLOBAL NEWS SOURCE OF MONEY MANAGEMENT. P&I'S 14TH ANNUAL RECOGNITION PROGRAM IS DEDICATED TO IDENTIFYING AND RECOGNIZING THE BEST EMPLOYERS IN THE MONEY MANAGEMENT INDUSTRY.

COHEN & STEERS NAMED A "BEST PLACE TO WORK IN MONEY MANAGEMENT" BY PENSIONS & INVESTMENTS FOR SIXTH CONSECUTIVE YEAR

ROCKVILLE, MD., DEC. 03, 2025 (GLOBE NEWSWIRE) -- SUPERNUS PHARMACEUTICALS, INC. (NASDAQ: SUPN), A BIOPHARMACEUTICAL COMPANY FOCUSED ON DEVELOPING AND COMMERCIALIZING PRODUCTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) DISEASES, ANNOUNCED TODAY THAT JACK A. KHATTAR, PRESIDENT AND CEO OF SUPERNUS PHARMACEUTICALS, WILL PRESENT AT THE BANK OF AMERICA SECURITIES 2025 CNS THERAPEUTICS VIRTUAL CONFERENCE ON MONDAY, DECEMBER 8, 2025, AT 3:20 P.M. ET.

SUPERNUS PHARMACEUTICALS TO PARTICIPATE IN THE BANK OF AMERICA SECURITIES 2025 CNS THERAPEUTICS VIRTUAL CONFERENCE

NEW YORK , NOV. 26, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (NYSE: RFI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON NOVEMBER 28, 2025AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2011, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (RFI) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , NOV. 26, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (NYSE: FOF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON NOVEMBER 28, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2021, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (FOF) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , NOV. 26, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS REIT AND PREFERRED AND INCOME FUND, INC. (NYSE: RNP) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON NOVEMBER 28, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2017, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS REIT AND PREFERRED AND INCOME FUND, INC. (RNP) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , NOV. 26, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (NYSE: RQI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON NOVEMBER 28, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2012, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (RQI) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

NEW YORK , NOV. 26, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON NOVEMBER 28, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN MARCH 2015, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS INFRASTRUCTURE FUND, INC. (UTF) NOTIFICATION OF SOURCES OF DISTRIBUTION UNDER SECTION 19(A)

CORAL GABLES, FLA., NOV. 24, 2025 (GLOBE NEWSWIRE) -- CATALYST PHARMACEUTICALS, INC. ("CATALYST" OR "COMPANY") (NASDAQ: CPRX), A COMMERCIAL-STAGE BIOPHARMACEUTICAL COMPANY FOCUSED ON IN-LICENSING, DEVELOPING, AND COMMERCIALIZING NOVEL MEDICINES FOR PATIENTS LIVING WITH RARE AND DIFFICULT-TO-TREAT DISEASES, TODAY ANNOUNCED THAT RICH DALY, PRESIDENT AND CEO, ALONG WITH OTHER MEMBERS OF CATALYST'S MANAGEMENT TEAM, WILL PARTICIPATE IN THE BANK OF AMERICA CNS THERAPEUTICS VIRTUAL CONFERENCE ON MONDAY, DECEMBER 8, 2025.

CATALYST PHARMACEUTICALS TO PARTICIPATE IN THE BANK OF AMERICA CNS THERAPEUTICS VIRTUAL CONFERENCE

CASH EXPECTED TO FUND OPERATIONS INTO THE SECOND HALF OF 2026 COMPANY FOCUSED ON ADVANCING NEXT-GENERATION ANTI-CANCER THERAPIES DERIVED FROM WELL-ESTABLISHED DRUG CLASSES, NOW ENGINEERED TO CROSS THE BLOOD-BRAIN BARRIER, POTENTIALLY ENHANCING EFFICACY FOR PATIENTS LEAD PROGRAM, TPI 287, PROGRESSING TOWARD PHASE 2 STUDY FOR TREATMENT OF GLIOBLASTOMA MULTIFORME (GBM), ONE OF THE MOST AGGRESSIVE TYPES OF BRAIN CANCER, WITH A MEDIAN SURVIVAL OF ONLY AROUND 15 MONTHS FROM THE TIME OF DIAGNOSIS HOUSTON, TX / ACCESS NEWSWIRE / NOVEMBER 17, 2025 / CNS PHARMACEUTICALS, INC. (NASDAQ:CNSP) ("CNS" OR THE "COMPANY"), A BIOPHARMACEUTICAL COMPANY SPECIALIZING IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR PRIMARY AND METASTATIC CANCERS IN THE BRAIN AND CENTRAL NERVOUS SYSTEM, TODAY REPORTED ITS FINANCIAL RESULTS FOR THE THIRD QUARTER ENDED SEPTEMBER 30, 2025 AND PROVIDED A CORPORATE UPDATE. "AS WE HEAD INTO THE FINAL QUARTER OF THE YEAR, OUR MISSION REMAINS CENTERED ON DELIVERING MEANINGFUL DEVELOPMENTS FOR PATIENTS BATTLING BRAIN AND CNS CANCERS.

CNS PHARMACEUTICALS REPORTS THIRD QUARTER 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE

NEW YORK , NOV. 14, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) ANNOUNCED TODAY PENDING CHANGES TO ITS GLOBAL REALTY MAJORS PORTFOLIO INDEX (GRM) AND INTERNATIONAL REALTY MAJORS PORTFOLIO INDEX (IRP), EFFECTIVE AS OF THE CLOSE OF BUSINESS ON NOVEMBER 21, 2025. COHEN & STEERS GLOBAL REALTY MAJORS PORTFOLIO INDEX (GRM) ADDED COMPONENT (SYMBOL)        REMOVED COMPONENT (SYMBOL) SWISS PRIME SITE AG (SPSN.SW) COVIVIO SA (COV.FP) COHEN & STEERS INTERNATIONAL REALTY MAJORS PORTFOLIO INDEX (IRP) ADDED COMPONENT (SYMBOL)        REMOVED COMPONENT (SYMBOL) SWISS PRIME SITE AG (SPSN.SW) COVIVIO SA (COV.FP) THESE FREE-FLOAT ADJUSTED, MODIFIED MARKET CAPITALIZATION-WEIGHTED TOTAL RETURN INDEXES OF SELECTED REAL ESTATE EQUITY SECURITIES ARE QUOTED INTRADAY ON A REAL-TIME BASIS BY THE CHICAGO MERCANTILE EXCHANGE.

COHEN & STEERS ANNOUNCES CHANGES TO REALTY INDEXES

NEW YORK , NOV. 13, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) ANNOUNCED TODAY THAT DANIEL NOONAN, EXECUTIVE VICE PRESIDENT AND HEAD OF GLOBAL WEALTH, HAS BEEN PROMOTED TO HEAD OF GLOBAL DISTRIBUTION. MR. NOONAN WILL LEAD ALL ASPECTS OF THE COMPANY'S BUSINESS DEVELOPMENT, CLIENT SERVICE AND MARKETING EFFORTS, PROVIDING STRATEGIC DIRECTION FOR BOTH INSTITUTIONAL AND WEALTH MARKETS GLOBALLY.

COHEN & STEERS PROMOTES DANIEL NOONAN TO HEAD OF GLOBAL DISTRIBUTION

NEW YORK , NOV. 10, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) TODAY REPORTED PRELIMINARY ASSETS UNDER MANAGEMENT OF $90.6 BILLION AS OF OCTOBER 31, 2025, A DECREASE OF $312 MILLION FROM ASSETS UNDER MANAGEMENT OF $90.9 BILLION AT SEPTEMBER 30, 2025. THE DECREASE WAS DUE TO MARKET DEPRECIATION OF $1.3 BILLION AND DISTRIBUTIONS OF $150 MILLION, PARTIALLY OFFSET BY NET INFLOWS OF $1.1 BILLION.

COHEN & STEERS ANNOUNCES PRELIMINARY ASSETS UNDER MANAGEMENT AND NET FLOWS FOR OCTOBER 2025

VANCOUVER, BRITISH COLUMBIA, NOV. 10, 2025 (GLOBE NEWSWIRE) -- RAKOVINA THERAPEUTICS INC. (RAKOVINA OR THE COMPANY) (TSX-V: RKV)(FSE: 7JO0) A BIOPHARMACEUTICAL COMPANY ADVANCING CANCER THERAPIES THROUGH AI-ENABLED DRUG DISCOVERY, TODAY ANNOUNCED THAT NEW DATA WILL BE PRESENTED IN TWO POSTERS AT THE SOCIETY FOR NEURO-ONCOLOGY (SNO) ANNUAL MEETING, TAKING PLACE NOVEMBER 1923, 2025, IN HONOLULU, HAWAII. THE PRESENTATIONS WILL HIGHLIGHT RAKOVINA'S AI-DRIVEN PROGRAMS TO DISCOVER AND DEVELOP NEXT-GENERATION DNA-DAMAGE RESPONSE (DDR) INHIBITORS ENGINEERED FOR CENTRAL NERVOUS SYSTEM (CNS) PENETRATION, SUPPORTING THE DEVELOPMENT OF POTENTIAL NEW TREATMENT OPTIONS FOR PRIMARY AND METASTATIC BRAIN CANCERS. PRESENTATION DETAILS:

RAKOVINA THERAPEUTICS TO PRESENT NEW DATA HIGHLIGHTING CNS-PENETRANT ATR AND PARP1 INHIBITORS AT THE 2025 SOCIETY FOR NEURO-ONCOLOGY ANNUAL MEETING

HOUSTON, TX / ACCESS NEWSWIRE / NOVEMBER 10, 2025 / CNS PHARMACEUTICALS, INC. (NASDAQ:CNSP) ("CNS" OR THE "COMPANY"), A BIOPHARMACEUTICAL COMPANY SPECIALIZING IN THE DEVELOPMENT OF NOVEL TREATMENTS FOR PRIMARY AND METASTATIC CANCERS IN THE BRAIN AND CENTRAL NERVOUS SYSTEM, TODAY ANNOUNCED THAT THREE ABSTRACTS HAVE BEEN SELECTED FOR POSTER PRESENTATION AT THE 2025 SNO ANNUAL MEETING BEING HELD NOVEMBER 19-23, 2025 IN HONOLULU, HI. DETAILS OF THE POSTER PRESENTATIONS ARE AS FOLLOWS: TITLE: ACTIVITY OF BERUBICIN AGAINST PEDIATRIC DIFFUSE MIDLINE GLIOMA (DMG) CELLS: PRELIMINARY DATA AND FUTURE POSSIBILITIES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: EXTH-133 DATE AND TIME: FRIDAY, NOVEMBER 21, 2025 AT 11:45 AM - 1:05 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III TITLE: TPI 287, WHICH IN COMBINATION WITH BEVACIZUMAB (BEV) HAS SHOWN ACTIVITY IN PATIENTS WITH GLIOBLASTOMA (GBM) AFTER PRIOR THERAPY, WILL BE EVALUATED IN A PHASE 2 TRIAL AS WELL AS IN OTHER CNS DISEASES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: CTNI-70 DATE AND TIME: SATURDAY, NOVEMBER 22, 2025 AT 11:45 AM - 1:05 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III TITLE: PRIMARY RESULTS OF THE RANDOMIZED CLINICAL TRIAL OF BERUBICIN VS LOMUSTINE IN PATIENTS WITH GLIOBLASTOMA AFTER FAILURE OF PRIMARY THERAPY: DATA ANALYSIS AND FUTURE POSSIBILITIES PRESENTER: SANDRA SILBERMAN, MD, PHD, CHIEF MEDICAL OFFICER OF CNS PHARMACEUTICALS ABSTRACT CODE: CTNI-74 DATE AND TIME: SATURDAY, NOVEMBER 22, 2025 AT 11:30 AM - 12:45 PM HST LOCATION: HAWAII CONVENTION CENTER, KAMEHAMEHA EXHIBIT HALL II & III FOR MORE INFORMATION ABOUT THE EVENT, PLEASE VISIT THE MEETING WEBSITE.

CNS PHARMACEUTICALS ANNOUNCES ACCEPTANCE OF THREE ABSTRACTS FOR POSTER PRESENTATION AT THE SOCIETY OF NUEROONCOLOGY (SNO) 30TH ANNUAL MEETING

MAJOR CUSTOMER RENEWAL, GLOBAL EXPANSION, AND NEW INNOVATIONS POSITION CORERO FOR CONTINUED GROWTH INTO 2026 LONDON , NOV. 5, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY REPORTED ACCELERATING GLOBAL GROWTH IN Q3 2025, FUELED BY RISING ORDER INTAKE AND CONTINUED INNOVATION ACROSS ITS SMARTWALL ONE PLATFORM, AND BEGAN Q4 WITH A MAJOR RENEWAL AND EXPANSION WITH A LEADING US CLOUD COMPUTING PROVIDER. BUILDING ON STRONG EXECUTION, CORERO ACHIEVED $7.4 MILLION IN Q3 ORDER INTAKE (UP FROM $6.0 MILLION IN Q3 2024) WITH NEW CUSTOMER WINS SPANNING THE US, UK, EUROPE, BRAZIL, AND SINGAPORE.

CORERO NETWORK SECURITY BUILDS ON Q3 EXECUTION WITH MAJOR Q4 WINS AND PRODUCT BREAKTHROUGHS

NEW YORK , OCT. 30, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF COHEN & STEERS, INC. (NYSE: CNS) DECLARED A CASH DIVIDEND FOR THE FOURTH QUARTER OF 2025 IN THE AMOUNT OF $0.62 PER SHARE OF COMMON STOCK PAYABLE ON NOVEMBER 20, 2025, TO STOCKHOLDERS OF RECORD AS OF THE CLOSE OF BUSINESS ON NOVEMBER 10, 2025. ABOUT COHEN & STEERS.

COHEN & STEERS, INC. DECLARES QUARTERLY DIVIDEND

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS CLOSED-END OPPORTUNITY FUND, INC. (NYSE: FOF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2021, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERSREIT AND PREFERRED AND INCOME FUND, INC. (NYSE: RNP) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE IN DECEMBER 2017, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION. THE MANAGED DISTRIBUTION POLICY SEEKS TO DELIVER THE FUND'S LONG-TERM TOTAL RETURN POTENTIAL THROUGH REGULAR MONTHLY DISTRIBUTIONS DECLARED AT A FIXED RATE PER COMMON SHARE.

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN MARCH 2015, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS QUALITY INCOME REALTY FUND, INC. (NYSE:RQI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025 AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2012, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITHEXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

NEW YORK , OCT. 28, 2025 /PRNEWSWIRE/ -- THIS PRESS RELEASE PROVIDES SHAREHOLDERS OF COHEN & STEERS TOTAL RETURN REALTY FUND, INC. (NYSE: RFI) (THE "FUND") WITH INFORMATION REGARDING THE SOURCES OF THE DISTRIBUTION TO BE PAID ON OCTOBER 31, 2025AND CUMULATIVE DISTRIBUTIONS PAID FISCAL YEAR-TO-DATE. IN DECEMBER 2011, THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

CUPERTINO, CALIF., OCT. 28, 2025 (GLOBE NEWSWIRE) -- REVIVA PHARMACEUTICALS HOLDINGS, INC. (NASDAQ: RVPH) (REVIVA OR THE COMPANY), A LATE-STAGE PHARMACEUTICAL COMPANY DEVELOPING THERAPIES THAT SEEK TO ADDRESS UNMET MEDICAL NEEDS IN THE AREAS OF CENTRAL NERVOUS SYSTEM (CNS), INFLAMMATORY AND CARDIOMETABOLIC DISEASES, TODAY ANNOUNCED THAT NEGATIVE SYMPTOM DATA FOR BRILAROXAZINE FROM THE PHASE 3 RECOVER DOUBLE-BLIND TRIAL IN PATIENTS WITH ACUTE EXACERBATION OF SCHIZOPHRENIA, AND FROM THE LONG-TERM OPEN-LABEL EXTENSION TRIAL IN CLINICALLY STABLE SCHIZOPHRENIA PATIENTS WILL BE PRESENTED AS A POSTER PRESENTATION AT THE CNS SUMMIT 2025, TAKING PLACE NOVEMBER 2-5, IN BOSTON, MASSACHUSETTS.

REVIVA TO PRESENT NEGATIVE SYMPTOM DATA FOR BRILAROXAZINE IN SCHIZOPHRENIA FROM THE PHASE 3 RECOVER DOUBLE-BLIND AND OPEN-LABEL EXTENSION TRIALS AT THE CNS SUMMIT 2025

NEW SMARTWALL ONE CAPABILITY STOPS HIDDEN L7 TLS ATTACKS IN REAL TIME WITHOUT LATENCY, DECRYPTION, OR ADDED INFRASTRUCTURE LONDON , OCT. 28, 2025 /PRNEWSWIRE/ -- CORERO NETWORK SECURITY (AIM: CNS) (OTCQX: DDOSF), A RECOGNIZED LEADER IN DDOS PROTECTION AND CHAMPION OF ADAPTIVE, REAL-TIME SERVICE AVAILABILITY, TODAY ANNOUNCED A NEW SMARTWALL ONE CAPABILITY THAT STOPS ENCRYPTED APPLICATION-LAYER ATTACKS IN REAL TIME WITHOUT ADDED LATENCY OR INFRASTRUCTURE. THE ENHANCEMENT ADDRESSES ONE OF THE MOST PRESSING BLIND SPOTS IN MODERN CYBERSECURITY.

CORERO NETWORK SECURITY SOLVES ENCRYPTED DDOS BLIND SPOT FOR SERVICE PROVIDERS AND ENTERPRISES

NEW YORK , OCT. 21, 2025 /PRNEWSWIRE/ -- THE BOARD OF DIRECTORS OF THE COHEN & STEERS INFRASTRUCTURE FUND, INC. (THE "FUND") ANNOUNCED TODAY THE MONTHLY DISTRIBUTIONS FOR NOVEMBER AND DECEMBER 2025, AS SUMMARIZED IN THE CHARTS BELOW: TICKER FUND NAME MONTHLY DIVIDEND UTF COHEN & STEERS INFRASTRUCTURE FUND, INC. $0.155 THE DISTRIBUTIONS WILL BE MADE ON THE FOLLOWING SCHEDULE: MONTH EX-DIVIDEND/ RECORD DATE PAYABLE DATE NOVEMBER NOV. 12, 2025 NOV. 28, 2025 DECEMBER DEC. 09, 2025 DEC. 31, 2025 THE FUND DECLARED ITS MONTHLY DISTRIBUTIONS PURSUANT TO THE FUND'S MANAGED DISTRIBUTION PLAN. THE FUND IMPLEMENTED A MANAGED DISTRIBUTION POLICY IN ACCORDANCE WITH EXEMPTIVE RELIEF ISSUED BY THE SECURITIES AND EXCHANGE COMMISSION.

COHEN & STEERS INFRASTRUCTURE FUND, INC. DECLARES DISTRIBUTIONS FOR NOVEMBER AND DECEMBER 2025

NEW YORK , OCT. 17, 2025 /PRNEWSWIRE/ -- COHEN & STEERS INFRASTRUCTURE FUND, INC. (NYSE: UTF) (THE "FUND") TODAY ANNOUNCED THE RESULTS OF ITS TRANSFERABLE RIGHTS OFFERING (THE "OFFER"), WHICH COMMENCED ON SEPTEMBER 22, 2025 AND EXPIRED ON OCTOBER 16, 2025 (THE "EXPIRATION DATE"). THE OFFERING WAS LED BY UBS INVESTMENT BANK AS THE SOLE DEALER MANAGER.

COHEN & STEERS INFRASTRUCTURE FUND, INC. ANNOUNCES PRELIMINARY RESULTS OF TRANSFERABLE RIGHTS OFFERING

NEW YORK , OCT. 16, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) TODAY REPORTED ITS RESULTS FOR THE QUARTER ENDED SEPTEMBER 30, 2025. THE EARNINGS RELEASE ALONG WITH THE ACCOMPANYING EARNINGS PRESENTATION CAN BE VIEWED AT COHEN & STEERS REPORTS RESULTS FOR THIRD QUARTER 2025 AND ON THE COMPANY'S WEBSITE AT WWW.COHENANDSTEERS.COMUNDER "COMPANYINVESTOR RELATIONSEARNINGS ARCHIVE.

COHEN & STEERS REPORTS RESULTS FOR THIRD QUARTER 2025

 AN ANALYSIS DESIGNED TO EVALUATE THE POTENTIAL EFFECTS OF THE PHASE 3 ZOREVUNERSEN DOSING REGIMEN SHOWED CONTINUING IMPROVEMENTS IN COGNITION AND BEHAVIOR AT 2 YEARS; RESULTS CONTRAST WITH MINIMAL CHANGE IN NATURAL HISTORY 

BIOGEN AND STOKE THERAPEUTICS PRESENT NEW DATA AT THE 54TH CHILD NEUROLOGY SOCIETY (CNS) ANNUAL MEETING THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

BEDFORD, MASS., & CAMBRIDGE, MASS.--(BUSINESS WIRE)--STOKE THERAPEUTICS, INC. (NASDAQ: STOK), A BIOTECHNOLOGY COMPANY DEDICATED TO RESTORING PROTEIN EXPRESSION BY HARNESSING THE BODY'S POTENTIAL WITH RNA MEDICINE, AND BIOGEN INC. (NASDAQ: BIIB) TODAY ANNOUNCED THE PRESENTATION OF LONGER-TERM FOLLOW-UP ANALYSES FROM THE ONGOING OPEN-LABEL EXTENSION (OLE) STUDIES OF ZOREVUNERSEN THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME. THESE NEW RESULTS WERE.

STOKE THERAPEUTICS AND BIOGEN PRESENT NEW DATA AT THE 54TH CHILD NEUROLOGY SOCIETY (CNS) ANNUAL MEETING THAT SUPPORT THE POTENTIAL OF ZOREVUNERSEN AS A DISEASE-MODIFYING MEDICINE FOR DRAVET SYNDROME

NEW YORK , OCT. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE: CNS) ANNOUNCED THAT IT EXPECTS TO RELEASE THIRD QUARTER 2025 RESULTS AFTER THE MARKET CLOSES ON THURSDAY, OCTOBER 16, 2025. THE EARNINGS RELEASE AND ACCOMPANYING EARNINGS PRESENTATION WILL BE AVAILABLE ON THE COMPANY'S WEBSITE AT WWW.COHENANDSTEERS.COMUNDER "COMPANYINVESTOR RELATIONSEARNINGS ARCHIVE.

COHEN & STEERS, INC. TO RELEASE THIRD QUARTER 2025 RESULTS ON OCTOBER 16, 2025

NEW YORK , OCT. 8, 2025 /PRNEWSWIRE/ -- COHEN & STEERS, INC. (NYSE:CNS) TODAY REPORTED PRELIMINARY ASSETS UNDER MANAGEMENT OF $90.9 BILLION AS OF SEPTEMBER 30, 2025, AN INCREASE OF $542 MILLION FROM ASSETS UNDER MANAGEMENT OF $90.4 BILLION AT AUGUST 31, 2025. THE INCREASE WAS DUE TO MARKET APPRECIATION OF $945 MILLION, PARTIALLY OFFSET BY DISTRIBUTIONS OF $322 MILLION AND NET OUTFLOWS OF $81 MILLION.

COHEN & STEERS ANNOUNCES PRELIMINARY ASSETS UNDER MANAGEMENT AND NET FLOWS FOR SEPTEMBER 2025

FEATURING DUREPAIR DURA REGENERATION MATRIX AND MAYFIELD GHOST BASE UNIT, POST FEATURING DUREPAIR DURA REGENERATION MATRIX AND MAYFIELD GHOST BASE UNIT, POST

Cohen & Steers, Inc.

CNS

Price

Financials Overview

Financial Reports

No items found.

Press Releases

Cohen & Steers, Inc.

CNS.css-1jgtvd5{-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;width:1em;height:1em;overflow:hidden;display:inline-block;text-align:center;-webkit-flex-shrink:0;-ms-flex-negative:0;flex-shrink:0;font-size:1.5rem;}

Price

Financials Overview

Financial Reports

No items found.

Press Releases

CNS